Over The Counter Brands

American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.

Walmart's flagship health and beauty private label brand with 75% U.S. household penetration, ranking as the second most popular store brand in America, offering over-the-counter medications and personal care products at affordable prices.

Over-the-counter antifungal medication for treating fungal infections including athlete's foot and toenail fungus, owned by Haleon plc.

American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.

Over-the-counter nasal decongestant spray for relieving nasal congestion from colds and allergies, owned by Haleon plc.

Over-the-counter and prescription medication for treating heartburn and acid reflux, manufactured and marketed by Merck & Co.

Over-the-counter cold and flu relief medication combining multiple active ingredients for symptom relief, owned by Haleon, a British consumer health company spun off from GSK in 2022.

American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023.

Over-the-counter anti-inflammatory pain relief brand containing diclofenac, owned by Haleon plc (LSE/NYSE: HLN) since its July 2022 spinoff from the GSK and Pfizer consumer health joint venture, with Voltaren growing mid-single digit in full-year 2025 supported by new format patches and Voltadexibu launches.

American brand of cetirizine antihistamine medication used to treat allergies without drowsiness, owned by Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023.